Sunscreen Overhaul Looms After Australia's SPF Failures

Australia’s medicines regulator has launched a broad plan to tighten how sunscreens are tested and marketed, after a high-profile episode in which many products did not match their advertised protection levels.

The Therapeutic Goods Administration (TGA) said Tuesday it is proposing reforms aimed at restoring confidence in SPF claims and improving product performance in a country that records the world’s highest skin-cancer rates.

What changed and why it matters now

The reform push follows a consumer advocacy group’s report last year that tested 20 sunscreens and found 16 did not deliver the stated Sun Protection Factor (SPF), including some positioned as premium products.

For Australia, the issue has direct public-health stakes: around 2,000 people die each year from skin cancer and melanoma, making the accuracy of protection claims a material concern for households and health systems.

What the TGA is proposing

The TGA’s package focuses on strengthening and widening testing requirements for sunscreens, alongside a requirement that laboratories conducting SPF testing be accredited.

It also aims to increase transparency around SPF claims, with the regulator flagging changes that would make it clearer how protection levels are determined and communicated to consumers.

Labeling changes under consideration

One of the most visible proposals is to simplify labels by potentially moving away from numeric SPF values and instead using descriptive bands such as low, medium, high, and very high.

The TGA has not confirmed a final labeling model, but the stated intent is to reduce confusion and make it easier for shoppers to compare products without relying solely on a number.

Scope of the review and what is excluded

The regulatory review will concentrate on the dependability of SPF testing and on ingredient quality in cosmetic sunscreens that claim high levels of protection.

The TGA said the safety of sunscreen ingredients is not part of this review, and products designed for children are also outside the scope.

Industry context and unresolved questions

The regulator previously examined concerns involving nearly two dozen products that shared a common base formulation, which it said may not have achieved the protection levels stated on packaging.

Key uncertainties remain, including how quickly any new testing and labeling rules would be implemented and what compliance costs could look like for brands and testing providers.